Patent details

Basic Information

Publication number:

EP1169059

PCT Application Number:

PCT/US/2000/009247

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009231564

PCT Publication Number:

WO/2000/061185

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DOCETAXEL IN COMBINATION WITH RHUMAB HER2 FOR THE TREATMENT OF CANCERS

French Title of Invention:

UTILISATION DE DOCETAXEL COMBINE A RHUMAB HER2 POUR LE TRAITEMENT DE CANCERS

German Title of Invention:

KOMBINATION VON DOCTAXEL UND RHUMAB HER2 ZÜR KREBSBEHANDLUNG

SPC Number:

Dates

Filing date:

07/04/2000

Grant date:

26/10/2005

EP Publication Date:

26/10/2005

PCT Publication Date:

19/10/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/01/2002

EP B1 Publication Date:

26/10/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/04/2018

Expiration date:

07/04/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/04/2000

 

 

Name:

Aventis Pharma S.A.

Address:

20, avenue Raymond Aron, 92165 Antony Cédex, France (FR)

Agent

Name:

VAN MALDEREN MICHEL

From:

05/12/2005

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

VOGEL Charles LE.

Address:

United States (US)

2

Name:

BELLET Robert, E.

Address:

United States (US)

Priority

Priority Number:

128564 P

Priority Date:

09/04/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/03/2017

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1